Potential effects of multimodal psychosomatic inpatient treatment for patients with functional vertigo and dizziness symptoms - A pilot trial.


Journal

Psychology and psychotherapy
ISSN: 2044-8341
Titre abrégé: Psychol Psychother
Pays: England
ID NLM: 101135751

Informations de publication

Date de publication:
03 2019
Historique:
received: 27 06 2017
revised: 26 02 2018
pubmed: 1 4 2018
medline: 9 3 2019
entrez: 1 4 2018
Statut: ppublish

Résumé

Functional vertigo and dizziness (VD) are frequent and severely distressing complaints that are often described as hard to treat. Our aim was to provide preliminary data on potential effects of multimodal psychosomatic inpatient therapy for patients with functional VD symptoms in reducing vertigo-related handicap and related psychopathology, and to evaluate the role of symptom burden and body-related locus of control in predicting vertigo-related handicap at follow-up. We conducted an uncontrolled clinical pilot trial. We included data of n = 72 inpatients with functional VD as a primary symptom and various psychopathological and/or physical comorbidities admitted for multimodal psychosomatic inpatient treatment. Patients completed self-report questionnaires assessing vertigo-related handicap (VHQ), somatization (PHQ-15), depression (BDI-II), anxiety (BAI), health-related quality of life (HRQOL; SF-36), and body-related locus of control (KLC) at admission (T0), discharge (T1), and 6 months after discharge (T2). We observed medium effects for the change of vertigo-related handicap (T0-T1: g = -0.60, T0-T2: g = -0.67) and small effects for the change of somatization (T0-T1: g = -0.29, T0-T2: g = -0.24), mental HRQOL (T0-T1: g = 0.43, T0-T2: g = 0.49), and depression (T0-T1: g = -0.41, T0-T2: g = -0.28) from admission to discharge and admission to follow-up. Body-related locus of control did not predict vertigo-related handicap at follow-up. Findings provide preliminary evidence for the beneficial role of psychosomatic inpatient treatment for patients with functional VD symptoms. Potentially relevant predictors of outcome at follow-up are discussed. The change of vertigo-related handicap and related variables through multimodal psychosomatic inpatient treatment was evaluated in a clinical pilot trial in patients with functional vertigo and dizziness. We observed medium effects for the change of vertigo-related handicap and small effects for the change of somatization, mental health-related quality of life, and depression. Internal body-related locus of control at admission did not predict vertigo-related handicap at follow-up.

Identifiants

pubmed: 29603590
doi: 10.1111/papt.12177
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-73

Informations de copyright

© 2018 The British Psychological Society.

Auteurs

Karina Limburg (K)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital of the Technical University of Munich, Germany.

Gabriele Schmid-Mühlbauer (G)

SchlaU-Schule (School for Young Refugees), Munich, Germany.

Heribert Sattel (H)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital of the Technical University of Munich, Germany.

Andreas Dinkel (A)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital of the Technical University of Munich, Germany.

Katharina Radziej (K)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital of the Technical University of Munich, Germany.

Melanie Gonzales (M)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital of the Technical University of Munich, Germany.

Joram Ronel (J)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital of the Technical University of Munich, Germany.

Claas Lahmann (C)

Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH